Skip to main content
OpenTrials
Completed

NCT Number: NCT03096119

A Study to Define the Distribution of Type of Hypertension in Asia by Blood Pressure Monitoring at Home (Asia BP@Home)

Blood pressure variability (BPV) is being increasingly recognized as an important influence on hypertension outcomes as well as a risk factor for other cardiovascular (CV) events. However, in Asia there is a current lack of awareness of BPV and its significance on patient outcomes. Furthermore, there is ongoing debate on the role of home blood pressure (HBP) monitoring in managing hypertension patients and uncertainty on how best to integrate it into clinical practice.

Therefore, we conduct Asia BP@Home study to assess HBP control status in each Asian country and develop an Asian consensus and Asia-specific treatment for hypertension.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hypertension Cardiovascular Diseases Vascular Diseases

Age range

20 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Jichi Medical University

Tochigi, Japan

About this study

Blood pressure variability (BPV) is being increasingly recognized as an important influence on hypertension outcomes as well as a risk factor for other cardiovascular (CV) events. However, in Asia there is a current lack of awareness of BPV and its significance on patient outcomes. Furthermore, there is ongoing debate on the role of home blood pressure (HBP) monitoring in managing hypertension patients and uncertainty on how best to integrate it into clinical practice.

The main purpose of this study is to:

  • Assess HBP control status in each Asian country
  • Develop an Asian consensus and Asia-specific treatment for hypertension
  • Improve the management of hypertension in Asia by encouraging patients to monitor HBP

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age >= 20 years
  • Subjects with stable medication (> 3 months) diagnosed as hypertension
  • Asian
  • Subjects have been thoroughly informed about this registry and signed an Informed Consent Form.

Exclusion criteria

-

Treatment and study plan

home blood pressure measurement

Other

We ask participants to measure their home blood pressure 7 days or more.

Primary outcomes

  1. Distribution rate based on the home BP of the patients.

    Time frame: 7 days or more blood pressure measurement

    Distribution rate based on the home BP of the patients who are defined as:

    • Masked morning hypertension
    • White-coat hypertension
    • Poorly controlled hypertension
    • Well controlled hypertension

Sponsors and collaborators

Lead sponsor

Jichi Medical University

Other

Registry information

Acronym: Asia BP@Home

Important dates

Study start
2017
Primary completion
2018
Study completion
2018
First posted
Mar 30, 2017
Registry last updated
Apr 17, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.